• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Concord Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 72610.0
  • ISIN : INE338H01029
1,740.70 -27 (-1.51%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    1,735.00

  • Today’s High

    1,790.70

  • Open

    1,758.60

  • Perv Close

    1,767.30

  • 52W Low

    1,345.00

  • 52W High

    2,664.00

Key Indicators

  • P/E(TTM)

    48.80

  • Mar.Cap (₹Cr.)

    18,210.54

  • Div & Yield %

    0.62

  • Book Value(₹)

    173.27

  • Debt-Equity Ratio

    -1.51

  • AGM Date

    01-Aug-2025

  • EPS

    35.65

  • P/E Ratio

    48.80

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    18,210.54

  • RONW (%)

    21.88

  • ROCE (%)

    29.05

Score Board

  • Equity (₹ in Cr.)

    10.46

  • BV (₹)

    173.30

  • Sales( ₹ in Cr.)

    1,200.09

  • NP (in Cr.)

    372.96

  • NP Var(%)

    27.0

  • Div%

    1070.0

  • CPS (₹)

    40.80

  • EPS (₹)

    35.70

  • Traded Value (₹ in Lakhs)

    18,200.08

  • 52 Week High

    2,664.00

  • 52 Week Low

    1,345.00

  • Price BSE

    1740.0

  • Price NSE

    1,741.00

  • Market Capital( in Cr.)

    18,200.08

  • P/C Ratio

    42.60

  • P/E Ratio

    48.80

  • Price Vs.BV

    35.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,016.94 853.17 712.93 616.94 512.33 436.01
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,016.94 853.17 712.93 616.94 512.33 436.01
Other Income 33.78 35.31 23.42 13.81 31.37 17.44
Stock Adjustments 12.08 15.63 23.98 39.05 4.85 1.16
Total Income 1,062.80 904.11 760.33 669.80 548.55 454.61
EXPENDITURE :            
Raw Materials 241.28 195.84 187.99 150.61 134.79 109.17
Power and Fuel Cost 104.97 97.65 71.64 39.86 37.30 36.29
Employee Cost 123.05 110.28 95.69 69.47 62.24 48.08
Other Manufacturing Expenses 28.00 24.93 17.10 12.99 30.93 12.53
Selling and Administration Expenses 91.08 82.93 67.90 44.87 31.74 35.72
Miscellaneous Expenses 8.46 13.20 22.66 10.26 15.65 14.90
Employee Benefit Expenses 123.05 110.28 95.69 69.47 62.24 48.08
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 596.83 524.84 462.99 328.05 312.65 256.69
Operating Profit 465.97 379.27 297.34 341.74 235.91 197.92
Interest 3.18 5.18 6.13 1.05 1.17 0.69
Gross Profit 462.79 374.09 291.21 340.69 234.74 197.23
Depreciation 53.59 54.03 50.05 27.52 21.25 19.31
Profit Before Tax 409.20 320.06 241.16 313.17 213.49 177.92
Current Tax 99.83 79.53 58.49 75.72 54.53 55.62
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.63 2.40 4.10 2.11 -10.00 3.91
Reported Net Profit 304.73 238.13 178.57 235.33 168.96 118.39
Extraordinary Items 10.48 2.70 3.86 5.24 17.47 1.53
Adjusted Net Profit 294.25 235.43 174.71 230.09 151.49 116.86
Adjustment below Net Profit -0.01 0.26 -0.56 -0.04 -0.84 0.14
P & L Balance brought forward 1,170.33 985.51 878.02 648.43 560.85 472.71
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 71.45 53.56 70.52 5.71 80.55 30.38
P & L Balance carried down 1,403.60 1,170.33 985.51 878.02 648.43 560.85
Dividend 0.00 0.00 0.00 0.00 0.00 25.20
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 875.00 683.00 51.20 0.00 392.50 264.50
Dividend Per Share(Rs) 8.75 6.83 5.12 0.00 39.25 26.45
Earnings Per Share-Unit Curr 29.13 22.76 187.76 247.44 177.66 124.48
Earnings Per Share(Adj)-Unit Curr 29.13 - - - - -
Book Value 145.80 123.50 1,164.13 1,051.11 809.71 717.62
Book Value(Adj)-Unit Curr 145.80 - - - - -

Shareholding Pattern

  • Promoter Group

    44.08%

  • Public Share Holding

    55.92%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41,364,608 39.54 41,364,608 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 46,116,608 44.08 46,116,608 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,526,075 9.11 9,526,075 105
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 3,572,562 3.41 3,572,562 6
Mutual Funds / UTI 4,898,388 4.68 4,898,388 22
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 804,513 0.77 804,513 11
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 18,801,538 17.97 18,801,538 144
2] Non Institution
Bodies Corporate 1,835,109 1.75 1,835,109 578
Clearing Members 77 0.00 77 3
Directors of their Relatives 210,000 0.20 210,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 2,092,325 2.00 2,092,325 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,291,267 2.19 2,291,267 1,101
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 197,071 0.19 197,071 2,552
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,256,432 1.20 1,256,432 1
Individuals holding nominal share capital up to Rs. 1 lakh 6,520,025 6.23 6,520,025 77,652
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 25,295,752 24.18 25,295,752 6
Others 0 0.00 0 0
Sub Total 39,698,058 37.95 39,698,058 81,895
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 104,616,204 100.00 104,616,204 82,045

Company Background

Concord Biotech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Concord Biotech Ltd
  • BSE Code : 72610.0
  • ISIN : INE338H01029

  • Incorporation Year

    1984

  • Registered Office

    1482-86 Trasad Road
    Dholka, Ahmedabad,
    Gujarat-382225

  • Telephone

    91-079-68138700

  • FAX

  • Chairman

    SUDHIR JAIRAM VAID

  • Managing Director

    SUDHIR JAIRAM VAID

  • Company Secretary

    S Prakash

  • Auditor

    Deloitte Haskins & Sells/BSR & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Concord Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Concord Biotech 1,739.70 1,050.72 1,016.94 48.80 28.81
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10